You searched for "therapeutics"
Development of retinoblastoma care in Indonesia and the role of multidisciplinary team meetings
In the second article of a two-part series (See Part 1 here), the authors focus on the diagnosis and management of retinoblastoma in Indonesia. COVID-19 doesn’t get thanked for many things, but on 19 December 2020 as the world grew...Addressing childhood blindness in sub-Saharan Africa
In this article, the authors explore paediatric ophthalmology subspecialist fellowship training in African nations south of the Sahara. Until recently, most African ophthalmologists who wished to pursue a subspecialty ophthalmology training fellowship had to go abroad. There is a huge...The Worshipful Company of Spectacle Makers rewards early career research
The Worshipful Company of Spectacle Makers (WCSM) this week announced the winners of its annual bronze medal award competitions for vision research. Both the winning submissions demonstrated models for earlier diagnosis of significant eye disease and have the capacity to...Early detection key to improving treatment of uveitis, a leading cause globally of vision loss
New treatment guidance has been developed to help doctors tackle uveitis — one of the leading causes of vision loss. The new clinical guidance, by a team at the University of Bristol, aims to help thousands of sufferers keep this...Stem cell therapy for Parkinson’s disease: researching for an effective cure
Neurodegenerative diseases are characterised by the chronic and progressive loss of neurons, which in turn results in loss of cognitive and physical functions. The World Health Organization has estimated that the disability-adjusted life years lost from neurological disease was about...First treatment for late-stage dry AMD rejected by UK drug regulator
Leading sight loss charity the Macular Society has responded to the decision not to approve the first potential treatment for geographic atrophy (GA) or late stage dry aged-related macular degeneration. The decision is a significant setback for those affected by...PREVIEW: International SPECTRALIS Symposium – AND BEYOND
The International SPECTRALIS Symposium (ISS) marks its 21st anniversary with an exciting new chapter in Heidelberg, Germany, just steps away from the headquarters of Heidelberg Engineering. Recognised as one of the most prestigious scientific imaging conferences, ISS 2025 will bring...
Ten-year experience with intracameral chemotherapy for aqueous seeding in retinoblastoma: long-term efficacy, safety and toxicity
This is a retrospective review of all consecutive patients with primary (n=4) or secondary non-iatrogenic (n=16) aqueous seeding (AS) treated by intracameral chemotherapy (ICC) in Lausanne between 2011 and 2020 with a minimum follow-up of one year. Aqueous seeding control...
Choroideremia in women
The authors report a questionnaire-based study of female carriers of choroideremia, an X-linked inherited chorioretinal dystrophy. As an X-linked condition the full clinical features are predominantly seen in men but a proportion of women suffer some morbidity, likely due to...
